Inhibikase Therapeutics, Inc. - COM NEW (IKT)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
836K
Holdings value Q2 2024
$1.02M
Value change Q2 2024
+$723K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
12
Number of buys Q2 2024
7
Number of sells Q2 2024
-6
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 836K $1.02M +$723K $1.21 12
2024 Q1 206K $444K -$62.2K $2.16 12
2023 Q4 235K $299K -$271K $1.27 11
2023 Q3 430K $598K -$497K $1.39 13
2023 Q2 747K $2.69M +$2.39M $3.61 14
2023 Q1 82.8K $54.5K +$54.5K $0.66 1